CeriBell Inc. Common Stock (CBLL)

About CBLL

CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals;…

Sector

Health Care

Industry

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Employees

327

Website

www.ceribell.com

Fundamentals

1-day range

$18.2$18.88

Market cap

$692.45M

P/E (trailing)

—

P/E (forward)

-17.13

EPS (trailing)

$-1.62

Dividend yield

—

Beta

—

Avg. volume

363.8K

Forecasts

7 analyst ratings

CeriBell Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• CBLL

  CeriBell Inc. Common Stock

  $23.73

  ▲ 1.54%
  Market cap $692.45MP/E —
  $10.85$24.33
• ELMD

  Electromed Inc. Common Stock

  $29.65

  ▼ 1.63%
  Market cap $348.09MP/E 34.86
  $23.01$47.4
• CV

  CapsoVision Inc. Common Stock

  $5.95

  ▼ 1.82%
  Market cap $344.75MP/E —
  $3.43$15.37
• FOCL

  EDAP TMS S.A. American Depositary Shares

  $4.3

  ▼ 0.92%
  Market cap $228.65MP/E —
  $4.01$6.4
• HSDT

  Solana Company Class A Common Stock (DE)

  $2.34

  ▼ 3.70%
  Market cap $98.09MP/E —
  $1.19$25.5
• HYPR

  Hyperfine Inc. Class A Common Stock

  $0.8358

  ▼ 1.09%
  Market cap $97.48MP/E —
  $0.831$2.22
• OM

  Outset Medical Inc. Common Stock

  $3.93

  ▼ 4.03%
  Market cap $96.39MP/E —
  $3$16.16

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Canaccord Genuity Maintains Buy on CeriBell, Raises Price Target to $26
  Benzinga · 8/11/2026
• BTIG Reiterates Buy on CeriBell, Maintains $28 Price Target
  Benzinga · 8/11/2026
• CeriBell, Inc. (CBLL) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/11/2026
• CeriBell Raises FY2026 Sales Guidance from $112.000M-$116.000M to $114.000M-$117.000M vs $113.979M Est
  Benzinga · 8/10/2026
• CeriBell Announces FDA 510(k) Clearance For Two New AI Algorithm Enhancements Integrated Directly Into Existing Cloud-Based Neurology Portal: Epileptiform Abnormality Detection And Artifact Reduction
  Benzinga · 8/10/2026
• CeriBell Says U.S. CMS Grants New Technology Add-On Payment For Up To $2,171 Per Eligible Medicare Patient Case Utilizing Ceribell Delirium Monitor System
  Benzinga · 8/3/2026

• Xingjuan Chao · August 3, 2026 · Option Exercise

  23.6K @ $4.7
• Xingjuan Chao · August 3, 2026 · Option Exercise

  1.4K @ $4.7
• Xingjuan Chao · August 3, 2026 · Sale

  39.0K @ $18.32
• Thomas A. West · July 28, 2026 · Grant

  16.0K
• Sharon O'Keefe · July 28, 2026 · Grant

  16.0K
• Xingjuan Chao · July 7, 2026 · Option Exercise

  23.6K @ $4.7
• Xingjuan Chao · July 7, 2026 · Option Exercise

  1.4K @ $4.7
• Xingjuan Chao · July 7, 2026 · Sale

  23.6K @ $19.9
• Xingjuan Chao · July 7, 2026 · Sale

  1.4K @ $19.9
• Xingjuan Chao · July 7, 2026 · Sale

  14.0K @ $19.9
• William W. Burke · June 30, 2026 · Sale

  2.2K @ $19.84
• Joseph Michael Taylor · June 11, 2026 · Sale

  5.5K @ $18.41
• Xingjuan Chao · June 8, 2026 · Option Exercise

  23.6K @ $4.7
• Xingjuan Chao · June 8, 2026 · Option Exercise

  1.4K @ $4.7
• Xingjuan Chao · June 8, 2026 · Sale

  23.6K @ $18.33

Institutional Ownership

March 31, 2026

Total shares held

29.21M

Total value held

$529.97M

Institutional holders

118